The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum
Open accessAbstract
Aims: We tested the hypothesis that candesartan improves outcomes in heart failure (HF) with mid-range ejection fraction [HFmrEF; ejection fraction (EF) 40–49%]. Methods and results: In 7598 patients enrolled in the CHARM Programme (HF across the spectrum of EF), we assessed characteristics, outcomes and treatment effect of candesartan according to EF. Patients with HFmrEF (n = 1322, 17%) were similar to those with HF with reduced EF (HFrEF; n = 4323, 57%) with respect to some characteristics, and intermediate between HFrEF and HF with preserved EF (HFpEF; n = 1953, 26%) with respect to others. Over a mean follow-up of 2.9 years, the incidence rates for the primary outcome of cardiovascular death or HF hospitalization were 15.9, 8.5 and 8.9 per 100 patient-years in HFrEF, HFmrEF and HFpEF. In adjusted analyses, the rates of the primary outcome declined with increasing EF up to 50%. For treatment effect, the incidence rates for the primary outcome for candesartan vs. placebo were 14.4 vs. 17.5 per 100 patient-years in HFrEF [hazard ratio (HR) 0.82, 95% confidence interval (CI) 0.75–0.91; P < 0.001], 7.4 vs. 9.7 per 100 patient-years in HFmrEF (HR 0.76, 95% CI 0.61–0.96; P = 0.02), and 8.6 vs. 9.1 per 100 patient-years in HFpEF (HR 0.95, 95% CI 0.79–1.14; P = 0.57). For recurrent HF hospitalization, the incidence rate ratios were 0.68 in HFrEF (95% CI 0.58–0.80; P < 0.001), 0.48 in HFmrEF (95% CI 0.33–0.70; P < 0.001), and 0.78 in HFpEF (95% CI 0.59–1.03; P = 0.08). With EF as a continuous spline variable, candesartan significantly reduced the primary outcome until EF well over 50% and recurrent HF hospitalizations until EF well over 60%. Conclusion: Candesartan improved outcomes in HFmrEF to a similar degree as in HFrEF. ClinicalTrials.gov: CHARM Alternative NCT00634400, CHARM Added NCT00634309, CHARM Preserved NCT00634712
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Self-citationLang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jev014 · Cited by 8,361
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866
Self-citationA Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Self-citationPfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Self-citationFonarow, G. C., Stough, W. G., Abraham, W. T., Albert, N. M., Gheorghiade, M., Greenberg, B. H., O’Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.064 · Cited by 1,092
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927
Self-citationSolomon, S. D., Anavekar, N., Skali, H., McMurray, J. J. V., Swedberg, K., Yusuf, S., Granger, C. B., Michelson, E. L., Wang, D., Pocock, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.561423 · Cited by 873
Self-citationMeta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr254 · Cited by 758
Solomon, S. D., Claggett, B., Lewis, E. F., Desai, A., Anand, I., Sweitzer, N. K., O'Meara, E., Shah, S. J., McKinlay, S., Fleg, J. L., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv464 · Cited by 532
Self-citationDiastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Borlaug, B. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.110.954388 · Cited by 456
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Sartipy, U., Dahlström, U., Fu, M., & Lund, L. H. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.05.001 · Cited by 383
Self-citationTsuji, K., Sakata, Y., Nochioka, K., Miura, M., Yamauchi, T., Onose, T., Abe, R., Oikawa, T., Kasahara, S., Sato, M., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.807 · Cited by 329
A Comprehensive Population-Based Characterization of Heart Failure with Mid-Range Ejection Fraction
Koh, A. S., Tay, W. T., Teng, T. H. K., Vedin, O., Benson, L., Dahlstrom, U., Savarese, G., Lam, C. S. P., & Lund, L. H. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.945 · Cited by 316
Self-citationSwedberg, K., Pfeffer, M., Granger, C., Held, P., Mcmurray, J., Ohlin, G., Olofsson, B., Östergren, J., & Yusuf, S. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90013-1 · Cited by 294
Self-citationVedin, O., Lam, C. S. P., Koh, A. S., Benson, L., Teng, T. H. K., Tay, W. T., Braun, O. Ö., Savarese, G., Dahlström, U., & Lund, L. H. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.117.003875 · Cited by 289
Self-citationLöfman, I., Szummer, K., Dahlström, U., Jernberg, T., & Lund, L. H. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.821 · Cited by 265
Self-citationPoppe, K. K., Doughty, R. N., Gardin, J. M., Hobbs, F. D. R., McMurray, J. J. V., Nagueh, S. F., Senior, R., Thomas, L., Whalley, G. A., Aune, E., et al. (2015) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2015.02.014 · Cited by 257
Self-citationThe Middle Child in Heart Failure: Heart Failure with Mid-Range Ejection Fraction (40–50%)
Lam, C. S. P., & Solomon, S. D. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.159 · Cited by 217
Self-citationRecovered Heart Failure with Reduced Ejection Fraction and Outcomes: A Prospective Study
Lupón, J., Díez-López, C., de Antonio, M., Domingo, M., Zamora, E., Moliner, P., González, B., Santesmases, J., Troya, M. I., & Bayés-Genís, A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.824 · Cited by 214
Solomon, S. D., Claggett, B., Desai, A. S., Packer, M., Zile, M., Swedberg, K., Rouleau, J. L., Shi, V. C., Starling, R. C., Kozan, Ö., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002744 · Cited by 206
Self-citationRickenbacher, P. R., Kaufmann, B. A., Maeder, M. T., Bernheim, A., Goetschalckx, K., Pfister, O., Pfisterer, M. E., Rocca, H. B., & for the TIME-CHF Investigators (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.798 · Cited by 156
Rastogi, A., Novak, E. L., Platts, A. E., & Mann, D. L. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.879 · Cited by 140
Microvascular endothelial dysfunction in heart failure with preserved ejection fraction
Lam, C. S. P., & Lund, L. H. (2016) · Heart · doi:10.1136/heartjnl-2015-308852 · Cited by 81
Self-citationNauta, J. F., Hummel, Y. M., van Melle, J. P., van der Meer, P., Lam, C. S. P., Ponikowski, P. P., & Voors, A. A. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1058 · Cited by 81
Self-citationLeft Ventricular Ejection Fraction and Heart Failure: An Indissoluble Marriage?
Mele, D., Nardozza, M., & Ferrari, R. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1071 · Cited by 69
Cited by
2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344
Self-citationHeidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Self-citationVan Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Self-citationDapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Claggett, B., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206286 · Cited by 2,884
Self-citation
Metadata
- Authors
- Lund, L. H., Claggett, B., Liu, J., Lam, C. S., Jhund, P. S., Rosano, G. M., Swedberg, K., Yusuf, S., Granger, C. B., Pfeffer, M. A., McMurray, J. J. V., & Solomon, S. D.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-12
- Volume
- 20
- Issue
- 8
- Pages
- 1230-1239
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2790275265
- Cited by
- 430
- References
- 27
- FWCI
- 29.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.